News & Articles

Novel column technology designed to put disease research and drug development on a more productive and efficient path

Watch this on-demand webinar to learn how to perform untargeted/semi-targeted metabolomic studies to discover novel biomarkers by mass spectrometry

The partnership aims to expand existing Monocyte Distribution Width (MDW) hematology-based biomarker to potentially aid in the rapid detection of MIS-C

The test uses a convolutional neural network to classify microscopy images of single intact particles of different viruses

In combination with other COVID-19 diagnostic tests, the Elecsys SARS-CoV-2 Antigen test can help in the management of patients for optimal care delivery

Miele’s latest range of professional washing machines and dryers promise to set new standards for the hygienic laundering of lab coats and protective clothing

Availability of the new IgM blood test on the ARCHITECT and Alinity platforms is part of Abbott's effort to offer tests across the disease progression of COVID-19

Easy-to-use test, which doesn't require specialized laboratory personnel or instruments, promises flexibility to test in locations that benefit from immediate results

The CTS Rotea system aims to help researchers overcome manufacturing hurdles and bring the vast potential of cell therapies to more patients

Find out how experts at the Ellison Institute are harnessing new cell monitoring technology to build cancer cell biobanks and enhance cell line quality control and authentication

Explore exclusive interviews, methods, and free downloads to help you optimize your mass spectrometry experiments

Join us on Thursday, October 29, to learn about the crucial role of food authenticity testing

Partnership combines Twist’s leadership in DNA synthesis and synthetic biology with Neogene’s expertise in personalized engineered T cell therapies

Summa Equity Fund II acquires a majority stake in Sengenics, a functional proteomics company with a unique technology for production of full-length, correctly folded and functional proteins

Antibodies available are specific for S1, S2 and receptor-binding domain regions of SARS-CoV-2 Spike protein